Anke Van der Perren

α-Synuclein strains cause distinct synucleinopathies after local and systemic administration

Wouter Peelaerts, Luc Bousset, Anke Van der Perren et al. · Nature · 2015 · 1.1K citations · Full text

Systemic Administration, Neuropathology

The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies

Anke Van der Perren, Géraldine Gelders, Alexis Fenyi et al. · Acta Neuropathologica · 2020 · 273 citations · Full text

rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration

Marusela Oliveras-Salvá, Anke Van der Perren, Nicolas Casadei et al. · Molecular Neurodegeneration · 2013 · 178 citations · Full text

Parkin Protects against Neurotoxicity in the 6-Hydroxydopamine Rat Model for Parkinson's Disease

Linda Vercammen, Anke Van der Perren, Elisabetta Vaudano et al. · Molecular Therapy · 2006 · 115 citations · Full text

Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors

Anke Van der Perren, Jaan Toelen, Cindy Casteels et al. · Neurobiology of Aging · 2014 · 106 citations · Full text

Robust Rat Model, Neurodegenerative Diseases, Adeno-associated Viral Vectors +6